• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Neoadjuvant Immunotherapy for Skin Cancer

by Jennifer Fink • April 18, 2023

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Jennifer Fink is a freelance medical writer based in Wisconsin.

You Might Also Like

  • New Findings Support Use of Cemiplimab as Neoadjuvant Therapy in Patients with Resectable Cutaneous Squamous Cell Carcinoma
  • Dermatologists, Otolaryngologists Differ on Skin Cancer Care
  • What’s New in Immunotherapy?
  • A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
Explore This Issue
April 2023

 

Needed: Multidisciplinary Squamous Cell Carcinoma Teams

Most cancer centers now have multidisciplinary melanoma teams and fantastic interdisciplinary head and neck cancer teams. But few centers have formal, organized multi-specialty teams to manage the care of patients with advanced cutaneous squamous cell carcinoma. As a result, these patients are often shuttled between dermatology and head and neck cancer practices—and the techniques used to manage advanced head and neck skin cancers are quite different from traditional treatments for localized skin cancer and tongue or tonsil cancers.

“We need multidisciplinary teams that are informed and dedicated to this patient population,” said Kevin Emerick, MD, co-director of the Non-Melanoma Skin Cancer Multidisciplinary Clinic and Program at Mass Eye and Ear in Boston.

If your institution or hospital doesn’t yet have a multidisciplinary team to manage locally advanced skin cancers, build connections with your colleagues in dermatology, plastic surgery, general surgery, surgical oncology, head and neck surgical oncology, and facial plastics. Patient involvement is also crucial; consider soliciting patient input and formally appointing patient representatives to steering committees, as appropriate.

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Features, Home Slider Tagged With: HN squamous cell carcinomas, Neoadjuvant ImmunotherapyIssue: April 2023

You Might Also Like:

  • New Findings Support Use of Cemiplimab as Neoadjuvant Therapy in Patients with Resectable Cutaneous Squamous Cell Carcinoma
  • Dermatologists, Otolaryngologists Differ on Skin Cancer Care
  • What’s New in Immunotherapy?
  • A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

What do you think about ankyloglossia?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • A Letter to My Younger Self: Making Deliberate Changes Can Help Improve the Sense of Belonging
  • ENTtoday Welcomes Resident Editorial Board Members
  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • Popular this Week
  • Most Popular
  • Most Recent
    • Exploring Controversies and Clinical Practices Surrounding Ankyloglossia

    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?

    • “Custom-Based Medicine,” Welcome to Reality!

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Unraveling the Mystery of Chronic Cough

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • “Custom-Based Medicine,” Welcome to Reality!
    • Exploring Controversies and Clinical Practices Surrounding Ankyloglossia
    • Otolaryngologists Outside the Office
    • The Power of AI in Otolaryngology
    • Secondary Contouring for the Butterfly Graft: Improving Form and Preserving Function

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939